Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4478)
All Articles published online
|
Dec 1, 2004 (publication date) through Jul 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10(23): 3459-3463 [PMID: 15526365 DOI: 10.3748/wjg.v10.i23.3459] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i23/3459.htm |
| Number | Citing Articles |
| 1 |
Ju Hoon Oh, Jung Ok Ban, Min-Chul Cho, Miran Jo, Jae Kyung Jung, Byeongwoo Ahn, Do-Young Yoon, Sang Bae Han, Jin Tae Hong. 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity. The Journal of Nutritional Biochemistry 2012; 23(7): 706 doi: 10.1016/j.jnutbio.2011.03.013
|
| 2 |
Courey Averett, Sumit Arora, Haseeb Zubair, Seema Singh, Arun Bhardwaj, Ajay P. Singh. Natural Products and Cancer Signaling: Isoprenoids, Polyphenols and Flavonoids. The Enzymes 2014; 36: 175 doi: 10.1016/B978-0-12-802215-3.00009-4
|
| 3 |
Azar Aghamohammadi, Seyed Jalal Hosseinimehr. Antiangiogenic Agents in Natural Products for the Treatment of Gynecologic Disorders. Nutrition and Cancer 2014; 66(2): 206 doi: 10.1080/01635581.2014.865136
|
| 4 |
Melissa E. Munroe, Jack L. Arbiser, Gail A. Bishop. Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis. The Journal of Immunology 2007; 179(2): 753 doi: 10.4049/jimmunol.179.2.753
|
| 5 |
Zhiyun He, Dharmalingam Subramaniam, Satish Ramalingam, Animesh Dhar, Russell G. Postier, Shahid Umar, Youcheng Zhang, Shrikant Anant. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(5): G929 doi: 10.1152/ajpgi.00159.2011
|
| 6 |
Katsumi Shigemura, Jack L. Arbiser, Shi‐Yong Sun, Majd Zayzafoon, Peter A.S. Johnstone, Masato Fujisawa, Akinobu Gotoh, Babette Weksler, Haiyen E. Zhau, Leland W.K. Chung. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 2007; 109(7): 1279 doi: 10.1002/cncr.22551
|
| 7 |
Mahmood Bahmani, Hedayatollah Shirzad, Najmeh Shahinfard, Laaleh Sheivandi, Mahmoud Rafieian-Kopaei. Cancer Phytotherapy. Journal of Evidence-Based Complementary & Alternative Medicine 2017; 22(2): 299 doi: 10.1177/2156587215625157
|
| 8 |
Michael McCulloch, Helen Ly, Michael Broffman, Caylie See, Jen Clemons, Raymond Chang. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer. Integrative Cancer Therapies 2016; 15(3): 285 doi: 10.1177/1534735416638738
|
| 9 |
Chih-Yeu Fang, Siang-Jyun Chen, Huey-Nan Wu, Yueh-Hsin Ping, Ching-Yen Lin, David Shiuan, Chi-Long Chen, Ying-Ray Lee, Kao-Jean Huang. Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection. Viruses 2015; 7(9): 4894 doi: 10.3390/v7092852
|
| 10 |
Ankit Kumar, Umesh Kumar Singh, Anurag Chaudhary. Honokiol Analogs: A Novel Class of Anticancer Agents Targeting Cell Signaling Pathways and Other Bioactivities. Future Medicinal Chemistry 2013; 5(7): 809 doi: 10.4155/fmc.13.32
|
| 11 |
Chunhua Yu, Qiuyang Zhang, Hui Ying Zhang, Xi Zhang, Xiaofang Huo, Edaire Cheng, David H. Wang, Jack L. Arbiser, Stuart Jon Spechler, Rhonda F. Souza. Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(5): G561 doi: 10.1152/ajpgi.00033.2012
|
| 12 |
Wenli Hou, Lijuan Chen, Guangli Yang, Hang Zhou, Qiqi Jiang, Zhenhua Zhong, Jia Hu, Xiang Chen, Xianhuo Wang, Yuan Yuan, Minghai Tang, Jing Wen, Yuquan Wei. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytotherapy Research 2008; 22(8): 1125 doi: 10.1002/ptr.2472
|
| 13 |
Jia Hu, Li-juan Chen, Li Liu, Xiang Chen, Ping Chen, Guang-li Yang, Wen-li Hou, Ming-hai Tang, Fan Zhang, Xian-huo Wang, Xia Zhao, Yu-quan Wei. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Experimental and Molecular Medicine 2008; 40(6): 617 doi: 10.3858/emm.2008.40.6.617
|
| 14 |
Anfernee Kai-Wing Tse, Chi-Keung Wan, Xiao-Ling Shen, Mengsu Yang, Wang-Fun Fong. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation. Biochemical Pharmacology 2005; 70(10): 1443 doi: 10.1016/j.bcp.2005.08.011
|
| 15 |
Jiexiang Yang, Yonggen Zou, Dianmin Jiang. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3433
|
| 16 |
Yang Wang, Ru-Yuan Yu, Qing-Yu He. Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/539260
|
| 17 |
Daniel G. Vassão, Kye-Won Kim, Laurence B. Davin, Norman G. Lewis. Comprehensive Natural Products II. 2010; : 815 doi: 10.1016/B978-008045382-8.00001-0
|
| 18 |
Abhishek Ranaware, Kishore Banik, Vishwas Deshpande, Ganesan Padmavathi, Nand Roy, Gautam Sethi, Lu Fan, Alan Kumar, Ajaikumar Kunnumakkara. Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer. International Journal of Molecular Sciences 2018; 19(8): 2362 doi: 10.3390/ijms19082362
|
| 19 |
Ruth Guillermo-Lagae, Sreevidya Santha, Milton Thomas, Emily Zoelle, Jonathan Stevens, Radhey S. Kaushik, Chandradhar Dwivedi. Antineoplastic Effects of Honokiol on Melanoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5496398
|
| 20 |
Literature Watch. Alternative and Complementary Therapies 2005; 11(2): 103 doi: 10.1089/act.2005.11.103
|
| 21 |
Yinfeng Dong, Minghai Tang, Hang Song, Rong Li, Chunyu Wang, Haoyu Ye, Neng Qiu, Yongkui Zhang, Lijuan Chen, Yuquan Wei. Characterization of metabolic profile of honokiol in rat feces using liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and 13C stable isotope labeling. Journal of Chromatography B 2014; : 20 doi: 10.1016/j.jchromb.2014.01.047
|
| 22 |
Chandeshwari Chilampalli, Ruth Guillermo, Radhey S Kaushik, Alan Young, Gudiseva Chandrasekher, Hesham Fahmy, Chandradhar Dwivedi. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. Experimental Biology and Medicine 2011; 236(11): 1351 doi: 10.1258/ebm.2011.011030
|
| 23 |
A. S. Prakasha Gowda, Zucai Suo, Thomas E. Spratt. Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells. Chemical Research in Toxicology 2017; 30(2): 715 doi: 10.1021/acs.chemrestox.6b00451
|
| 24 |
Andrey V. Shubin, Ilya V. Demidyuk, Alexey A. Komissarov, Lola M. Rafieva, Sergey V. Kostrov. Cytoplasmic vacuolization in cell death and survival. Oncotarget 2016; 7(34): 55863 doi: 10.18632/oncotarget.10150
|
| 25 |
Aleksandra Mędra, Magdalena Witkowska, Agata Majchrzak, Barbara Cebula-Obrzut, Michael Bonner, Tadeusz Robak, Jack Arbiser, Piotr Smolewski. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules 2016; 21(8): 995 doi: 10.3390/molecules21080995
|
| 26 |
Eun‐Ryeong Hahm, A. Isabella Karlsson, Michael Y. Bonner, Jack L. Arbiser, Shivendra V. Singh. Honokiol inhibits androgen receptor activity in prostate cancer cells. The Prostate 2014; 74(4): 408 doi: 10.1002/pros.22762
|
| 27 |
Jing Pan, Yongik Lee, Qi Zhang, Donghai Xiong, Tina C. Wan, Yian Wang, Ming You. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Cancer Prevention Research 2017; 10(2): 133 doi: 10.1158/1940-6207.CAPR-16-0129
|
| 28 |
Kao‐Jean Huang, Chin‐Ho Kuo, Shu‐Hsin Chen, Ching‐Yen Lin, Ying‐Ray Lee. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. Journal of Cellular and Molecular Medicine 2018; 22(3): 1894 doi: 10.1111/jcmm.13474
|
| 29 |
Gang Chen, Feng Wang, Dunyaporn Trachootham, Peng Huang. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 2010; 10(6): 614 doi: 10.1016/j.mito.2010.08.001
|
| 30 |
Tripti Singh, Santosh K. Katiyar, Xianglin Shi. Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling. PLoS ONE 2013; 8(4): e60749 doi: 10.1371/journal.pone.0060749
|
| 31 |
Chia-Hsien Chen, Chang-Jung Chiang, Lien-Chen Wu, Chih-Hong Yang, Yi-Jie Kuo, Tung-Hu Tsai. In vitro Penetration and in vivo Distribution of Honokiol into the Intervertebral Disc in Rat. Analytical Sciences 2015; 31(12): 1297 doi: 10.2116/analsci.31.1297
|
| 32 |
Parteek Prasher, Rabab Fatima, Mousmee Sharma, Bekzat Tynybekov, Asma M. Alshahrani, Dilek Arslan Ateşşahin, Javad Sharifi-Rad, Daniela Calina. Honokiol and its analogues as anticancer compounds: Current mechanistic insights and structure-activity relationship. Chemico-Biological Interactions 2023; 386: 110747 doi: 10.1016/j.cbi.2023.110747
|
| 33 |
WEI TIAN, YONGCHUAN DENG, LING LI, HAIFEI HE, JIE SUN, DONG XU. Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death. International Journal of Oncology 2013; 42(2): 721 doi: 10.3892/ijo.2012.1739
|
| 34 |
Gaurav Kaushik, Deep Kwatra, Dharmalingam Subramaniam, Roy A. Jensen, Shrikant Anant, Joshua M.V. Mammen. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. The American Journal of Surgery 2014; 208(6): 995 doi: 10.1016/j.amjsurg.2014.09.014
|
| 35 |
Ding Lin, Zhongzhong Yan, Aiyu Chen, Jiao Ye, Aixi Hu, Juan Liu, Junmei Peng, Xiaoyun Wu. Anti-proliferative activity and structure-activity relationship of honokiol derivatives. Bioorganic & Medicinal Chemistry 2019; 27(16): 3729 doi: 10.1016/j.bmc.2019.06.042
|
| 36 |
Traci E. Battle, Jack Arbiser, David A. Frank. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 2005; 106(2): 690 doi: 10.1182/blood-2004-11-4273
|
| 37 |
Xiaodong Shi, Langsheng Yang, Jihai Gao, Yuzhen Sheng, Xiaoqing Li, Yunjie Gu, Guoqing Zhuang, Fang Chen. Deep sequencing of Magnoliae officinalis reveals upstream genes related to the lignan biosynthetic pathway. Journal of Forestry Research 2017; 28(4): 671 doi: 10.1007/s11676-016-0356-5
|
| 38 |
Ling Li, Weidong Han, Ying Gu, Shuang Qiu, Qinghua Lu, Jie Jin, Jianhong Luo, Xun Hu. Honokiol Induces a Necrotic Cell Death through the Mitochondrial Permeability Transition Pore. Cancer Research 2007; 67(10): 4894 doi: 10.1158/0008-5472.CAN-06-3818
|
| 39 |
Chih-Jung Yao, Gi-Ming Lai, Chi-Tai Yeh, Ming-Tang Lai, Ping-Hsiao Shih, Wan-Ju Chao, Jacqueline Whang-Peng, Shuang-En Chuang, Tung-Yuan Lai. Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/146136
|
| 40 |
Keng-li Lan, Keng-hsin Lan, Meei-ling Sheu, Ming-yuan Chen, Yi-sheng Shih, Fu-chih Hsu, Hong-Ming Wang, Ren-shyan Liu, Sang-hue Yen. Honokiol inhibits hypoxia-inducible factor-1 pathway. International Journal of Radiation Biology 2011; 87(6): 579 doi: 10.3109/09553002.2011.568572
|
| 41 |
JUNG-IL CHAE, YOUNG-JOO JEON, JUNG-HYUN SHIM. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells. Oncology Reports 2013; 29(6): 2318 doi: 10.3892/or.2013.2353
|
| 42 |
Zhu Yuan, Huanyi Liu, Fei Yan, Yongsheng Wang, Lantu Gou, Chunlai Nie, Zhenyu Ding, Songtao Lai, Yuwei Zhao, Xinyu Zhao, Jiong Li, Hongxin Deng, Yongqiu Mao, Lijuan Chen, Yuquan Wei, Xia Zhao. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS‐4, a novel pro‐apoptotic gene. Cancer Science 2009; 100(9): 1757 doi: 10.1111/j.1349-7006.2009.01242.x
|
| 43 |
Haixia Ji, Ou Qiao, Yi Zhang, Wenzhe Wang, Xiaoyin Han, Xinyu Zhang, Changxiao Liu, Wenyuan Gao. Dual targeting of wild‐type p53 and gut microbiota by Magnolol represses key metabolic process and kills CRC cells. Phytotherapy Research 2023; doi: 10.1002/ptr.7924
|
| 44 |
Tripti Singh, Ram Prasad, Santosh K. Katiyar. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics 2013; 8(1): 54 doi: 10.4161/epi.23078
|
| 45 |
Mohanad Zbidah, Adrian Lupescu, Tabea Herrmann, Wenting Yang, Michael Foller, Kashif Jilani, Florian Lang. Effect of honokiol on erythrocytes. Toxicology in Vitro 2013; 27(6): 1737 doi: 10.1016/j.tiv.2013.05.003
|
| 46 |
NJ Lee, JH Oh, JO Ban, JH Shim, HP Lee, JK Jung, BW Ahn, DY Yoon, SB Han, YW Ham, JT Hong. 4‐O‐methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21‐mediated suppression of NF‐κB activity. British Journal of Pharmacology 2013; 168(5): 1133 doi: 10.1111/j.1476-5381.2012.02235.x
|
| 47 |
Tianyu Wang, Hui Wang, Fan Yang, Kuan Gao, Shuya Luo, Lichuan Bai, Ke Ma, Mei Liu, Shuwei Wu, Huijie Wang, Zaixing Chen, Qinghuan Xiao. Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+‐activated Cl− channels. British Journal of Pharmacology 2021; 178(20): 4137 doi: 10.1111/bph.15606
|
| 48 |
Min Suk Seo, Jung Hwan Kim, Hye Jung Kim, Ki Churl Chang, Sang Won Park. Honokiol activates the LKB1–AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Toxicology and Applied Pharmacology 2015; 284(2): 113 doi: 10.1016/j.taap.2015.02.020
|
| 49 |
Yasmeen Ezzeldeen, Shady Swidan, Aliaa ElMeshad, Aya Sebak. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. International Journal of Nanomedicine 2021; : 5693 doi: 10.2147/IJN.S314472
|
| 50 |
Huanli Xu, Wei Tang, Guanhua Du, Norihiro Kokudo. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of <i>Magnolia officinalis </i>. Drug Discoveries & Therapeutics 2011; 5(5): 202 doi: 10.5582/ddt.2011.v5.5.202
|
| 51 |
So Yong Lee, Dong Yeon Yuk, Ho Seub Song, Do Young Yoon, Jae Kyung Jung, Dong Cheul Moon, Byung Seok Lee, Jin Tae Hong. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-κB. European Journal of Pharmacology 2008; 582(1-3): 17 doi: 10.1016/j.ejphar.2007.12.027
|
| 52 |
Ling-Li Han, Li-Ping Xie, Ling-Hui Li, Xiao-Wen Zhang, Rong-Qing Zhang, Hong-Zhong Wang. Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells. Environmental Toxicology and Pharmacology 2009; 28(1): 97 doi: 10.1016/j.etap.2009.03.005
|
| 53 |
Eun-Ryeong Hahm, Shivendra V. Singh. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Molecular Cancer Therapeutics 2007; 6(10): 2686 doi: 10.1158/1535-7163.MCT-07-0217
|
| 54 |
Chie Ishikawa, Jack L. Arbiser, Naoki Mori. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. Biochimica et Biophysica Acta (BBA) - General Subjects 2012; 1820(7): 879 doi: 10.1016/j.bbagen.2012.03.009
|
| 55 |
Shruti M. Raja, Shuzhen Chen, Ping Yue, Timothy M. Acker, Benjamin Lefkove, Jack L. Arbiser, Fadlo R. Khuri, Shi-Yong Sun. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis. Molecular Cancer Therapeutics 2008; 7(7): 2212 doi: 10.1158/1535-7163.MCT-07-2409
|
| 56 |
Donald R. Yance, Stephen M. Sagar. Targeting Angiogenesis With Integrative Cancer Therapies. Integrative Cancer Therapies 2006; 5(1): 9 doi: 10.1177/1534735405285562
|
| 57 |
Eun-Ryeong Hahm, Kozue Sakao, Shivendra V. Singh. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. The Prostate 2014; 74(12): 1209 doi: 10.1002/pros.22837
|
| 58 |
Patrick Steinmann, Denise K. Walters, Matthias J. E. Arlt, Ingo J. Banke, Urs Ziegler, Bettina Langsam, Jack Arbiser, Roman Muff, Walter Born, Bruno Fuchs. Antimetastatic activity of honokiol in osteosarcoma. Cancer 2012; 118(8): 2117 doi: 10.1002/cncr.26434
|
| 59 |
Md. Faysal, Jishan Khan, Mehrukh Zehravi, Nikhil Nath, Laliteshwar Pratap Singh, Saloni Kakkar, Rajashekar Perusomula, Pathan Amanulla Khan, Firzan Nainu, Mohammed Asiri, Sharuk L. Khan, Rajib Das, Talha Bin Emran, Polrat Wilairatana. Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00846-1
|
| 60 |
Ekaterina I. Mikhaevich, Danila V. Sorokin, Alexander M. Scherbakov. Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin. Research in Pharmaceutical Sciences 2023; 18(5): 580 doi: 10.4103/1735-5362.383712
|
| 61 |
Fatima Khatoon, Sabeeha Ali, Vijay Kumar, Abdelbaset Mohamed Elasbali, Hassan H. Alhassan, Salem Hussain Alharethi, Asimul Islam, Md. Imtaiyaz Hassan. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics 2023; 41(15): 7511 doi: 10.1080/07391102.2022.2120541
|
| 62 |
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, Mohamed Abdel-Aziz. STAT3 transcription factor as target for anti-cancer therapy. Pharmacological Reports 2020; 72(5): 1101 doi: 10.1007/s43440-020-00156-5
|
| 63 |
Eun-Ryeong Hahm, Krishna Beer Singh, Shivendra V. Singh. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Cell Cycle 2016; 15(17): 2309 doi: 10.1080/15384101.2016.1201253
|
| 64 |
C.-K. Chiang, M.-L. Sheu, K.-Y. Hung, K.-D. Wu, S.-H. Liu. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney International 2006; 70(4): 682 doi: 10.1038/sj.ki.5001617
|
| 65 |
Peramaiyan Rajendran, Feng Li, Muthu K. Shanmugam, Shireen Vali, Taher Abbasi, Shweta Kapoor, Kwang Seok Ahn, Alan Prem Kumar, Gautam Sethi. Honokiol inhibits signal transducer and activator of transcription‐3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP‐1. Journal of Cellular Physiology 2012; 227(5): 2184 doi: 10.1002/jcp.22954
|
| 66 |
Emma E. Ramsay, Philip J. Hogg, Pierre J. Dilda. Mitochondrial Metabolism Inhibitors for Cancer Therapy. Pharmaceutical Research 2011; 28(11): 2731 doi: 10.1007/s11095-011-0584-5
|
| 67 |
Young-Jung Lee, Yoot Mo Lee, Chong-Kil Lee, Jae Kyung Jung, Sang Bae Han, Jin Tae Hong. Therapeutic applications of compounds in the Magnolia family. Pharmacology & Therapeutics 2011; 130(2): 157 doi: 10.1016/j.pharmthera.2011.01.010
|
| 68 |
Pamela Ovadje, Alessia Roma, Matthew Steckle, Leah Nicoletti, John Thor Arnason, Siyaram Pandey. Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/751348
|
| 69 |
Dan Liu, Linjiang Wang, Henan Li, Dong Li, Jianwen Zhou, Jing Wang, Qi Zhang, Defu Cai. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma. Molecules 2024; 29(3): 675 doi: 10.3390/molecules29030675
|
| 70 |
Rebecca J. Leeman-Neill, Quan Cai, Sonali C. Joyce, Sufi M. Thomas, Neil E. Bhola, Daniel B. Neill, Jack L. Arbiser, Jennifer R. Grandis. Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors. Clinical Cancer Research 2010; 16(9): 2571 doi: 10.1158/1078-0432.CCR-10-0333
|
| 71 |
KEN-HU CHANG, MING-DE YAN, CHIH-JUNG YAO, PEI-CHUN LIN, GI-MING LAI. Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. Oncology Letters 2013; 6(5): 1435 doi: 10.3892/ol.2013.1548
|
| 72 |
Wenxia Sun, Cuiting Lv, Tonghan Zhu, Xue Yang, Shanjian Wei, Jieyin Sun, Kui Hong, Weiming Zhu, Caiguo Huang. Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells. Marine Drugs 2013; 11(11): 4570 doi: 10.3390/md11114570
|
| 73 |
Dong Xu, Qinghua Lu, Xun Hu. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Letters 2006; 243(2): 274 doi: 10.1016/j.canlet.2005.11.031
|
| 74 |
Zhengyu Li, Yi Liu, Xia Zhao, Xiaoling Pan, Rutie Yin, Canhua Huang, Lijuan Chen, Yuquan Wei. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008; 140(1): 95 doi: 10.1016/j.ejogrb.2008.02.023
|
| 75 |
Mohamed Saeed, Victor Kuete, Onat Kadioglu, Jonas Börtzler, Hassan Khalid, Henry Johannes Greten, Thomas Efferth. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 2014; 21(12): 1525 doi: 10.1016/j.phymed.2014.07.011
|
| 76 |
Jing Pan, Yongik Lee, Yian Wang, Ming You. Honokiol targets mitochondria to halt cancer progression and metastasis. Molecular Nutrition & Food Research 2016; 60(6): 1383 doi: 10.1002/mnfr.201501007
|
| 77 |
Hanyan Luo, Hongwei Wu, Xiankuo Yu, Xiao Zhang, Yaqi Lu, Jianwei Fan, Liying Tang, Zhuju Wang. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. Journal of Ethnopharmacology 2019; 236: 412 doi: 10.1016/j.jep.2019.02.041
|
| 78 |
Yi-Ren Chen, Pei-Wen Hsiao, Feng-Ming Lin, Guan-James Wu, Chin-Hsien Tsai. Materia Medica for Various Cancers. Evidence-based Anticancer Complementary and Alternative Medicine 2012; 2: 103 doi: 10.1007/978-94-007-1983-5_6
|
| 79 |
Kangmao Huang, Yanyan Chen, Rui Zhang, Yizheng Wu, Yan Ma, Xiangqian Fang, Shuying Shen. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0166-5
|
| 80 |
Stephen M. Sagar, Raimond K. Wong. Supportive Cancer Care with Chinese Medicine. 2010; : 109 doi: 10.1007/978-90-481-3555-4_6
|
| 81 |
Sumit Arora, Arun Bhardwaj, Sanjeev K. Srivastava, Seema Singh, Steven McClellan, Bin Wang, Ajay P. Singh, Dhyan Chandra. Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells. PLoS ONE 2011; 6(6): e21573 doi: 10.1371/journal.pone.0021573
|
| 82 |
Abdur Rauf, Seema Patel, Muhammad Imran, Aneela Maalik, Muhammad Umair Arshad, Farhan Saeed, Yahia N. Mabkhot, Salim S. Al-Showiman, Nazir Ahmad, Eman Elsharkawy. Honokiol: An anticancer lignan. Biomedicine & Pharmacotherapy 2018; 107: 555 doi: 10.1016/j.biopha.2018.08.054
|
| 83 |
Liang Ma, Jinying Chen, Xuewei Wang, Xiaolin Liang, Youfu Luo, Wei Zhu, Tianen Wang, Ming Peng, Shucai Li, Shi Jie, Aihua Peng, Yuquan Wei, Lijuan Chen. Structural Modification of Honokiol, a Biphenyl Occurring in Magnolia officinalis: the Evaluation of Honokiol Analogues as Inhibitors of Angiogenesis and for Their Cytotoxicity and Structure–Activity Relationship. Journal of Medicinal Chemistry 2011; 54(19): 6469 doi: 10.1021/jm200830u
|
| 84 |
Hsiu-Chung Ou, Fen-Pi Chou, Tsung-Min Lin, Ching-Hwa Yang, Wayne Huey-Herng Sheu. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Chemico-Biological Interactions 2006; 161(1): 1 doi: 10.1016/j.cbi.2006.02.006
|
| 85 |
Chon Phin Ong, Wai Leong Lee, Yin Quan Tang, Wei Hsum Yap. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers 2019; 12(1): 48 doi: 10.3390/cancers12010048
|
| 86 |
Keng‐Hsin Lan, Ying‐Wen Wang, Wei‐Ping Lee, Keng‐Li Lan, Szu‐Han Tseng, Li‐Rong Hung, Sang‐Hue Yen, Han‐Chieh Lin, Shou‐Dong Lee. Multiple effects of honokiol on the life cycle of hepatitis C virus. Liver International 2012; 32(6): 989 doi: 10.1111/j.1478-3231.2011.02621.x
|
| 87 |
Y. LIU, L. CHEN, X. HE, L. FAN, G. YANG, X. CHEN, X. LIN, L. DU, Z. LI, H. YE, Y. MAO, X. ZHAO, Y. WEI. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. International Journal of Gynecological Cancer 2008; 18(4): 652 doi: 10.1111/j.1525-1438.2007.01070.x
|
| 88 |
Hongmei Li, Xianfeng Wang, Yuzhu Hu. Distinct Photoacidity of Honokiol from Magnolol. Journal of Fluorescence 2011; 21(1): 265 doi: 10.1007/s10895-010-0714-1
|
| 89 |
Ling Li, Qinghua Lu, Yanwei Shen, Xun Hu. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochemical Pharmacology 2006; 71(5): 584 doi: 10.1016/j.bcp.2005.11.026
|
| 90 |
B. Ling, S.-F. Liang, Y.-H. Xu, X.-Y. Zhao, M.-H. Tang, X.-Y. Liu, X. Zhao, C.-H. Huang, L.-J. Chen, Y.-Q. Wei. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy. Amino Acids 2008; 35(1): 115 doi: 10.1007/s00726-007-0615-z
|
| 91 |
Yinglin Zuo, Yi Yu, Shuni Wang, Weiyan Shao, Binhua Zhou, Li Lin, Zhuoyu Luo, Ruogu Huang, Jun Du, Xianzhang Bu. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition. European Journal of Medicinal Chemistry 2012; 50: 393 doi: 10.1016/j.ejmech.2012.02.023
|
| 92 |
Wei-Zhe Liang, Chiang-Ting Chou, Hong-Tai Chang, Jin-Shiung Cheng, Daih-Huang Kuo, Kuang-Chung Ko, Ni-Na Chiang, Ru-Fang Wu, Pochuen Shieh, Chung-Ren Jan. The mechanism of honokiol-induced intracellular Ca2+ rises and apoptosis in human glioblastoma cells. Chemico-Biological Interactions 2014; 221: 13 doi: 10.1016/j.cbi.2014.07.012
|
| 93 |
D. Ainbinder, R. Protokin, M. Chaouat, E. Touitou. Effect of honokiol and 5-FU on non-melanoma skin cancer cells. Journal of Drug Delivery Science and Technology 2009; 19(4): 283 doi: 10.1016/S1773-2247(09)50053-6
|
| 94 |
Xi Dai, Run-Ze Li, Ze-Bo Jiang, Chun-Li Wei, Lian-Xiang Luo, Xiao-Jun Yao, Guo-Ping Li, Elaine L.-H. Leung. Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00558
|
| 95 |
Eun-Ryeong Hahm, Julie A. Arlotti, Stanley W. Marynowski, Shivendra V. Singh. Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis Induction. Clinical Cancer Research 2008; 14(4): 1248 doi: 10.1158/1078-0432.CCR-07-1926
|
| 96 |
Gaurav Kaushik, Anand Venugopal, Prabhu Ramamoorthy, David Standing, Dharmalingam Subramaniam, Shahid Umar, Roy A. Jensen, Shrikant Anant, Joshua M.V. Mammen. Honokiol inhibits melanoma stem cells by targeting notch signaling. Molecular Carcinogenesis 2015; 54(12): 1710 doi: 10.1002/mc.22242
|
| 97 |
Mélanie Poivre, Pierre Duez. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. Journal of Zhejiang University-SCIENCE B 2017; 18(3): 194 doi: 10.1631/jzus.B1600299
|
| 98 |
Chandraiah Godugu, Ravi Doddapaneni, Mandip Singh. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). Colloids and Surfaces B: Biointerfaces 2017; 153: 208 doi: 10.1016/j.colsurfb.2017.01.038
|
| 99 |
Kishore Banik, Abhishek Manoj Ranaware, Vishwas Deshpande, Savita Pravin Nalawade, Ganesan Padmavathi, Devivasha Bordoloi, Bethsebie Lalduhsaki Sailo, Muthu K. Shanmugam, Lu Fan, Frank Arfuso, Gautam Sethi, Ajaikumar B. Kunnumakkara. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019; 144: 192 doi: 10.1016/j.phrs.2019.04.004
|
| 100 |
Su-Kyung Lee, Hye-Nan Kim, Yeong-Rim Kang, Chang Woo Lee, Hwan-Mook Kim, Dong Cho Han, Jongheon Shin, KiHwan Bae, Byoung-Mog Kwon. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorganic & Medicinal Chemistry 2008; 16(18): 8397 doi: 10.1016/j.bmc.2008.08.033
|
| 101 |
Melissa E. Munroe, Thomas R. Businga, Joel N. Kline, Gail A. Bishop. Anti-Inflammatory Effects of the Neurotransmitter Agonist Honokiol in a Mouse Model of Allergic Asthma. The Journal of Immunology 2010; 185(9): 5586 doi: 10.4049/jimmunol.1000630
|
| 102 |
Maurizio Coppola, Raffaella Mondola. Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. Medical Hypotheses 2014; 83(6): 673 doi: 10.1016/j.mehy.2014.09.015
|
| 103 |
Jung Min Song, Arunkumar Anandharaj, Pramod Upadhyaya, Ameya R. Kirtane, Jong-Hyuk Kim, Kwon Ho Hong, Jayanth Panyam, Fekadu Kassie. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 2016; 7(36): 57752 doi: 10.18632/oncotarget.10759
|